Pfizer Requests Full Approval of its COVID-19 Vaccine
By EsqSocial Corporation 12/05/21
On Friday, May 7, Pfizer and its partner BioNTech filed an application seeking full approval from the United States Food and Drug Administration (FDA) for its COVID-19 vaccine for patients age 16 and up. Pfizer is the first COVID-19 vaccine producer to do so. Full approval would allow Pfizer to market and distribute its vaccine without seeking a new emergency authorization. It would also represent an official acknowledgment from the FDA that the benefits of the vaccine outweigh any risks. The...
By: Ballard Spahr LLP